Digital Transformation

Astellas' approach to DX is much more than simply streamlining operations through digital technology. We implement DX to realize our VISION: To be on the forefront of healthcare change to turn innovative science into VALUE for patients.

  

Astellas’ DX Vision

Astellas' DX Vision is to "become a world-class Intelligent Enterprise that accelerates digital transformation to turn innovative science to VALUE for patients." We have identified four levers (sources of value) centered around Digital x Data to realize our DX vision.
 

digital-transformation_image1_en.png

 

  • Sense (Use sensory devices to collect various types of events as data)
  • Analyze (Utilize and analyze all data to forecast the future and support bold and accurate decision-making early on)
  • Automate (Use digital for high quality, fast operations)
  • Engage (Use a combination of digital and analogue to connect people across time and space)

By combining these four levers with our company's accumulated knowledge of science, we believe we can realize value chain that provides superior pharmaceuticals and acquire competitive superiority.

 

Why are we focused on DX?

The pharmaceutical industry handles vast amounts of data throughout its entire value chain from research, development, and manufacturing, to sales and the post-marketing maximization of our product value.

digital-transformation_image2_en_20221013.png

Consultants analyzing the potential impact of DX on the pharmaceutical industry have highlighted huge benefits for drug R&D over the next 15 to 20 years. These include the possibility of a 60% reduction in cost and a shortened timeframe of approximately 2.4 years*1 in drug research & development.

*1 “With advances in (digital) technology, (omitted) it will be possible, 15 to 20 years from now, to reduce the cost of pharmaceutical research and development by about 60% and shorten the development period by about 2.4 years.” https://www2.deloitte.com/jp/ja/pages/life-sciences-and-healthcare/articles/ls/brnp-v1.html

In today’s increasingly globalized marketplace, we currently conduct business in more than 70 countries worldwide. Our DX initiatives are executed globally to achieve results that will significantly impact our entire group.

 

Astellas is driving DX initiatives throughout its entire value chain and business, including in back office and security systems that support the value chain. We are also developing our Rx+® business to develop solutions that bring VALUE to patients throughout the entire patient journey.

Click below to read more.